Rothamsted Research

where knowledge grows

The first GM oilseed crop to produce omega-3 fish oils in the field

Camelina oilseed plants

Scientists at Rothamsted Research announce the first year results of the field-scale trial of Camelina oilseed plants genetically engineered to make omega-3 fish oils in their seeds.

In a landmark paper published today in the journal Metabolic Engineering Communications, scientists at Rothamsted Research have announced the first year results of the field-scale trial of Camelina oilseed plants genetically engineered to make omega-3 fish oils in their seeds.

Omega-3 fish oils specifically long-chain polyunsaturated fatty acids (omega-3 LC-PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are acknowledged by the medical community to be beneficial components of the human diet. The primary dietary sources of EPA & DHA are marine fish, either wild or farmed (aquaculture). Although some types of omega-3 fats are available from other sources in the human diet (such as flax seeds), the nutritionally-beneficial omega- 3 LC- PUFA EPA & DHA are only available from marine sources. Fish, like humans, accumulate the omega-3 fish oils by feeding on other organisms in the marine food chain or, in the case of farmed fish, through fishmeal and fish oil in feed.

Farmed fish is a rapidly growing sector, and today over half of the fish consumed worldwide comes from aquaculture. As the production of fish through aquaculture increases so does the need to find alternative sources of omega-3 fish oils. Rothamsted's new data - which demonstrate an important proof of concept that a crop plant can be engineered to synthesise these beneficial fatty acids in seeds - provide hope for sustainable land-based sources of omega-3 fish oils, thereby releasing pressure from the oceans.

Dr Olga Sayanova, the senior Rothamsted Researcher who developed the GM Camelina plants, commented: “We are delighted with the results of our first year field trial. Finding a land-based source of feedstocks containing omega-3 fish oils has long been an urgent priority for truly sustainable aquaculture. Our results give hope that oilseed crops grown on land can contribute to improving the sustainability of the fish farming industry and the marine environment in the future."

Rothamsted scientists, strategically funded by the BBSRC, have already shown that they can successfully engineer Camelina sativa plants to produce non-native EPA and DHA, by introducing a set of seven synthetic genes based on the DNA sequences found in photosynthetic marine organisms. Although previous experiments in glasshouses had given positive indications for the performance of this trait, this trial demonstrated the stability of the trait and the ability of the GM Camelina plants to synthesise useful quantities of fish oils without any negative effects on yield. Monitoring of the plants grown in the field showed no obvious phenotypic differences in the growth, flowering or seed-set of the GM Camelina plants when compared to the non-GM control plants.

Professor Johnathan Napier, leading the GM Camelina programme at Rothamsted Research, said: “The omega-3 fish oil trait that we have developed is probably the most complex example of plant genetic engineering to be tested in the field. This is a globally-significant proof of concept and a landmark moment in the effort to develop truly sustainable sources of feed for fish farms.”

The field trial conducted at Rothamsted Research’s experimental farm continues this year.  In the field this year two GM Camelina lines are sown as well as the non – GM controls.  One line is the same as the one described in the current publication making EPA and DHA. The second one is a GM Camelina line that makes only EPA. Analyses and comparisons will be conducted between the two lines.

The field trial and the associated laboratory analyses are funded by the government-supported Biotechnology and Biological Sciences Research Council (BBSRC).  The scientific paper published today is available in open-source format from the journal Metabolic Engineering Communications.

Contacts

Notes to Editors

The humble willow basket to be remembered at First World War event

Celebrate the importance of the humble willow basket during the First World War, with the Everyday Day Lives in War Centre and Rothamsted Research, on Saturday 12th November 2016.

Rothamsted Research submits application to Defra for permission to carry out field trial with GM wheat plants

The trial will test whether GM wheat plants are able to carry out photosynthesis more efficiently in the field and whether this trait could result in a higher yielding crop. A public consultation has begun.

Learning from the “healthy” to protect the “infected”

A novel mechanism has been identified which likely contributes to resistance against Septoria leaf blotch in plant species normally non-infected with the disease, providing the clues necessary to develop control methods in wheat.

State of Nature report: views from Rothamsted Research

Rothamsted Research scientists comment on the 2016 State of Nature report.

Pages

Rothamsted Press Office

For further information, please contact:

Dr Matina Tsalavouta (matina.tsalavouta@rothamsted.ac.uk), Tel: +44 (0) 1582 938 525

About Rothamsted Research

We are the longest running agricultural research station in the world, providing cutting-edge science and innovation for over 170 years. Our mission is to deliver the knowledge and new practices to increase crop productivity and quality and to develop environmentally sustainable solutions for food and energy production.

Our strength lies in the integrated, multidisciplinary approach to research in plant, insect and soil science.

Rothamsted Research is strategically funded by the Biotechnology and Biological Sciences Research Council (BBSRC). In 2013-2014 Rothamsted Researched received a total of £32.9M from the BBSRC.

About BBSRC

The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by Government, BBSRC invested over £509M in world-class bioscience in 2014-15. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.

For more information about BBSRC, our science and our impact see: http://www.bbsrc.ac.uk

For more information about BBSRC strategically funded institutes see: http://www.bbsrc.ac.uk/institutes